News
Researchers with City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U ...
and additionally on day 183 for participants who were acetylcholine receptor antibody–positive) or matching placebo for 52 weeks (in participants who were acetylcholine receptor antibody ...
The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who have acetylcholine receptor antibody–positive generalized myasthenia ...
Inebilizumab is a monoclonal antibody that causes sustained depletion of CD19-positive B cells. It was approved in 2020 to treat neuromyelitis optica spectrum disorder (NMOSD) patients who are ...
Hosted on MSN18d
iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays BearishShares of iBio, Inc.(IBIO) were in the spotlight on Monday after the company announced positive data from a study conducted in animals for its lead asset IBIO-600. The company said data from a ...
This important work presents a stochastic branching process model of tumour-immune coevolution, incorporating stochastic antigenic mutation accumulation and escape within the cancer cell population.
This study provides valuable findings on the role of site-specific DNA methylation changes during spermatogenesis and their contribution to paternal epigenetic inheritance. The study proposes that ...
No intrinsic risk factor was associated with EMTP in women. EMTP was the major cause for non-completion of the run component of the ADFA fitness test in both men and women. Conclusions: Greater ...
New data presented at the American College of Cardiology 2025 Annual Scientific Session found that patients with type 2 diabetes taking an oral formulation of the glucagon-like peptide-1 (GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results